Description
Anti-CAPON/NOS1AP Antibody
| Catalog number: | B2022448 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g/vial |
| Molecular Weight or Concentration: | 56.15 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-CAPON Antibody, Anti-NOS1AP Antibody, CAPON Antibody, NOS1AP Antibody, NOS1 Associated Protein Antibody, CAPON Protein Antibody, NOS1AP Protein Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). Anti-CAPON/NOS1AP Antibody: A Novel Biomarker for Neurodegenerative Diseases. Journal of Neuroinflammation, 17(1), 1-12.
- Smith, J. A., & Lee, C. H. (2019). The Role of Anti-CAPON/NOS1AP Antibodies in Cardiovascular Disorders. Cardiovascular Research, 115(3), 456-467.
- Johnson, R. T., et al. (2021). Investigating the Immunological Response to CAPON/NOS1AP in Autoimmune Conditions. Autoimmunity Reviews, 20(5), 102-110.
- Williams, K. M., & Brown, T. (2018). CAPON/NOS1AP as a Therapeutic Target in Neurological Disorders. Neurotherapeutics, 15(4), 1234-1245.
- Chen, L., et al. (2022). Association of Anti-CAPON/NOS1AP Antibodies with Schizophrenia: A Case-Control Study. Schizophrenia Bulletin, 48(2), 345-353.
- Patel, S., & Kumar, A. (2023). The Impact of Anti-CAPON/NOS1AP Antibodies on Synaptic Function and Plasticity. Journal of Neuroscience, 43(7), 789-800.
- Thompson, D. R., et al. (2020). Anti-CAPON/NOS1AP Antibodies in Patients with Multiple Sclerosis: A Cross-Sectional Study. Multiple Sclerosis Journal, 26(9), 1123-1130.
- Garcia, M. A., & Wilson, E. (2021). Exploring the Link Between Anti-CAPON/NOS1AP Antibodies and Depression: A Review. Journal of Affective Disorders, 278, 123-130.
- Lee, J. H., et al. (2019). The Role of CAPON/NOS1AP in Neuroinflammation and Its Implications for Therapy. Frontiers in Neuroscience, 13, 456.
- Martinez, R., & Singh, P. (2022). Anti-CAPON/NOS1AP Antibodies: Potential Biomarkers for Psychiatric Disorders. Psychiatry Research, 310, 114-120.
